登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Nature，3月25日，Management of IBD during the COVID-19 outbreak: resetting clinical priorities》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-26

  • Management of IBD during the COVID-19 outbreak: resetting clinical priorities

    Silvio Danese, Maurizio Cecconi & Antonino Spinelli

    Nature Reviews Gastroenterology & Hepatology (2020)

    The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we describe the fast changes and clinical issues that IBD specialists could face during this SARS-CoV-2 infection pandemic, highlighting the potential rearrangements of care and resetting of clinical priorities.

  • 原文来源：https://www.nature.com/articles/s41575-020-0294-8
24浏览量
原文链接
相关报告

  • 《Nature，3月26日，Seven tips to manage your mental health and well-being during the COVID-19 outbreak》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-28
    • Seven tips to manage your mental health and well-being during the COVID-19 outbreak Feeling overwhelmed by a lockdown and the need to suddenly adopt e-learning? Keep connected and compassionate, says clinical psychologist Desiree Dickerson. I am a clinical psychologist who specializes in academic mental health and well-being. In mid-March I was due to run a resilience and well-being workshop in Sweden for doctoral candidates, but was instead facing day eight of quarantine with two small children in my apartment in Spain. Like many people’s, my sense of resilience feels increasingly frayed. When our minds are consumed by the spread of the coronavirus and its impact on our health, loved ones, home countries, economy and students — not to mention our research programme, funding or employment status, and an abrupt transition to e-learning — how do we maintain our own mental health and well-being and that of our community?
    25浏览量
    原文链接

  • 《Nature，3月19日，Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-20
    • Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China Joseph T. Wu, Kathy Leung, Mary Bushman, Nishant Kishore, Rene Niehus, Pablo M. de Salazar, Benjamin J. Cowling, Marc Lipsitch & Gabriel M. Leung Nature Medicine (2020) Abstract As of 29 February 2020 there were 79,394 confirmed cases and 2,838 deaths from COVID-19 in mainland China. Of these, 48,557 cases and 2,169 deaths occurred in the epicenter, Wuhan. A key public health priority during the emergence of a novel pathogen is estimating clinical severity, which requires properly adjusting for the case ascertainment rate and the delay between symptoms onset and death. Using public and published information, we estimate that the overall symptomatic case fatality risk (the probability of dying after developing symptoms) of COVID-19 in Wuhan was 1.4% (0.9–2.1%), which is substantially lower than both the corresponding crude or naïve confirmed case fatality risk (2,169/48,557 = 4.5%) and the approximator1 of deaths/deaths + recoveries (2,169/2,169 + 17,572 = 11%) as of 29 February 2020.
    88浏览量
    原文链接